PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
More and more people are turning to nootropics or 'smart drugs' to enhance their cognitive ability. But what do they do, what are the risks and where do the ethical
Connected brand experiences can drive social conversation and deeper engagement
The variety and variability of European health technology assessment criteria have created a challenging environment for pharma and a need for much greater harmonisation
Building pharma brands driven by customer-focused innovation will enable companies to differentiate their products in a crowded marketplace
Table listing all the major pharma mergers, acquisitions and collaborations in the past month
Astellas’ vice president of marketing, Europe and its chief strategy officer, Europe discuss category leadership, the changing landscape of market access and growth in a time of austerity
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Patricia Hewitt will serve private health firm as non-executive director
International business intelligence solutions underpinned by global or regional enterprise data warehouses are failing with millions of dollars wasted
US state attorney general takes issue with auto-complete and ad policies